Description

Description

Linjardy MXR 5/2.5/1000mg is a once-daily, extended-release triple combination tablet that brings together three distinct anti-diabetic mechanisms in a single pill, packaged 14 tablets to a pack. It combines Empagliflozin, an SGLT2 inhibitor that helps the kidneys clear excess glucose through urine, Linagliptin, a DPP-4 inhibitor that supports insulin release around mealtimes while reducing the liver’s glucose output, and an extended-release form of Metformin, which steadily improves the body’s sensitivity to its own insulin throughout the day. Bringing three complementary pathways together into one tablet is intended for patients whose blood sugar isn’t adequately managed by one or two mechanisms alone, offering a more comprehensive approach while keeping the daily pill count manageable.

Ingredients

Each Linjardy MXR 5/2.5/1000mg tablet contains:

• Empagliflozin – 5 mg (immediate-release layer)
• Linagliptin – 2.5 mg
• Metformin Hydrochloride – 1000 mg (extended-release core)

The tablet also contains standard inactive excipients that form the extended-release matrix and outer film coating, which regulate the gradual release of Metformin and support easy swallowing, without any therapeutic effect of their own.

Dosage Form

Linjardy MXR 5/2.5/1000mg is manufactured as an extended-release, film-coated oral tablet, supplied 14 tablets per pack, intended for once-daily oral use.

Uses

Linjardy MXR 5/2.5/1000mg is generally prescribed to:

• Improve blood glucose control in adults with type 2 diabetes mellitus who are not adequately managed on one or two of the three individual components
• Allow patients already stabilized on Empagliflozin, Linagliptin, and Metformin taken as separate medicines to transition to a simpler once-daily triple-combination tablet
• Support long-term diabetes management, including potential cardiovascular and kidney-related benefits, when paired with an appropriate diet and consistent physical activity

It is not intended for people with type 1 diabetes or for the management of diabetic ketoacidosis.

How to Use

The following points are general guidance only — always follow the specific instructions given by your prescribing doctor:

• Take the tablet once daily, generally with the evening meal, as directed by your doctor.
• Swallow the tablet whole with a glass of water; because it is extended-release, never crush, split, or chew it, as this can cause the metformin dose to release too quickly.
• It’s normal to occasionally notice the outer tablet shell in the stool, since this part of the extended-release matrix is not fully absorbed; this does not mean the medicine was ineffective.
• Maintain a consistent daily timing to help support stable blood sugar management.
• Attend recommended blood tests, including kidney function monitoring, since safe use of this triple combination depends on adequate kidney health.

Side Effects

Side effects can vary between individuals, but commonly reported ones with this combination include:

• Nausea, diarrhea, or general stomach discomfort, typically milder than with immediate-release metformin, especially once the body adjusts
• Increased urinary frequency
• Mild dehydration or increased thirst
• Urinary tract or genital yeast infections
• Upper respiratory symptoms such as a runny or stuffy nose

Less commonly, more serious concerns can occur, including lactic acidosis (a rare but serious risk associated with metformin, more likely with reduced kidney or liver function), signs of pancreatitis such as persistent abdominal pain, joint pain associated with DPP-4 inhibitors, or symptoms suggesting diabetic ketoacidosis such as ongoing nausea, vomiting, or abdominal pain even when blood glucose readings appear normal. Any of these symptoms warrant urgent medical attention. This overview is not exhaustive, so any unusual or persistent symptom should be discussed with a doctor or pharmacist.

Pregnancy & Breastfeeding

Linjardy MXR is generally not recommended during pregnancy, since the Empagliflozin component may affect fetal kidney development, particularly in later stages of pregnancy, and diabetes management in pregnant women is typically handled through alternative approved treatments under specialist care. It is also generally not advised while breastfeeding. Women who are pregnant, planning to become pregnant, or currently breastfeeding should speak with their doctor before starting or continuing this medication.

Storage Instructions

• Store Linjardy MXR tablets at room temperature, ideally below 25°C, away from direct sunlight, heat, and excess humidity.
• Keep tablets in their original blister packaging until they are needed.
• Store out of reach of children.
• Do not use tablets past their printed expiry date, and dispose of unused medicine responsibly rather than through household waste.

FAQS

Why does Linjardy MXR combine three medicines instead of two?
Some patients need support from all three glucose-lowering pathways, insulin-related, kidney-based, and liver/insulin sensitivity, to achieve adequate blood sugar control, and combining them reduces the number of separate pills needed.

Why can’t I crush or split this tablet?
Doing so would disrupt the extended-release mechanism, causing the full metformin dose to release at once instead of gradually, which increases the risk of digestive side effects.

Is it normal to notice the tablet shell in my stool?
Yes, the outer matrix that controls the slow release of metformin is not fully absorbed and may appear intact in the stool; this does not mean the dose was ineffective.

Can Linjardy MXR be combined with insulin?
It may sometimes be used alongside insulin under close medical supervision, though this combination increases the risk of low blood sugar and requires careful monitoring.

Why is kidney function monitored so closely with this medicine?
Because both the Metformin and Empagliflozin components depend on adequate kidney function to work safely, regular monitoring helps ensure the combination remains appropriate for you.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.